Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced…
VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene therapy…
Switch Automation and Berkeley Lab Advance Next Generation of Smart Buildings—From Analytics to Autonomous Operations Switch Automation, a global provider of smart building software, today announced the release of new product capabilities in Switch OpX (Operational Excellence), developed in collaboration…
Nick Dokoozlian Named Recipient of Triple Helix AgTech Leadership Prize Triple Helix Institute for Agriculture, Climate, and Society a nonprofit dedicated to building cross-sector engagement and public understanding around agriculture technology (AgTech), today announced Dr. Nick Dokoozlian as the recipient…
Valo Health Appoints Chris Anagnostopoulos, PhD, as Chief Causal AI Officer Valo Health, Inc. a pioneer in the use of human data and AI to accelerate drug discovery and development, announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the…
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training Compass Pathways plc a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced an invitation for U.S. based organizations to apply…
Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome Quiver Bioscience a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, today announced…
Emalex Receives U.S. Patent for Orally Disintegrating Ecopipam Formulation Emalex Biosciences announced that the U.S. Patent and Trademark Office issued a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 receptor antagonist in development for the…
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system GE HealthCare integrates bkActiv™ with the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during…
Chevron Confirms Oil Discovery at Bandit Prospect in Gulf of America Chevron Corporation confirmed an oil discovery at the Bandit prospect in the Gulf of America, as announced by operator Occidental. The exploration well is located in Green Canyon Block…
Trinity Launches InsightsEDGE™ Digital Twins — Generative AI Unlocks Always-On Intelligence for Life Sciences Commercial Teams Trinity today announced broad launch of InsightsEDGE™ | Digital Twins, a market tested AI-solution that creates interactive virtual replicas of HCPs, patients, and payers, grounded…
Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics Thermo Fisher Scientific Inc. the world leader in serving science, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the…